MedTrace Logo

Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes

NCT03930004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-10-08

No results posted yet for this study

Summary

Type 1 diabetes mellitus is a chronic autoimmune disease, associated with an increased risk of cardiovascular diseases. The development of cardiomyopathy in type 1 diabetes, independent of hypertension and coronary heart disease, is still controversial. A possible mechanism for diabetic cardiomyopathy is autonomic dysfunction. This study aims to evaluate cardiac function and structure, and to relate them with autonomic dysfunction in type 1 diabetes.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetic Cardiomyopathies
  • Autonomic Neuropathy, Diabetic

Sponsors & Collaborators

  • Roberto Léo da Silva

    lead OTHER

Principal Investigators

  • Thais R Weber, MD · HU/UFSC

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-06
Primary Completion
2019-08-01
Completion
2019-09-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03930004 on ClinicalTrials.gov